Skip to content

Clinical trials

Active, not recruiting Myelodysplastic Syndromes trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Active, not recruiting Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20192
20202
20211
20222
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Novartis Pharmaceuticals3
AbbVie1
Agios Pharmaceuticals, Inc.1
Associazione Qol-one1
Celgene1
Eli Lilly and Company1
GWT-TUD GmbH1
Geron Corporation1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes14
Anemia5
Leukemia, Myeloid, Acute3
Leukemia, Myelomonocytic, Chronic3
Thrombocytopenia2
Anemia, Refractory, with Excess of Blasts1
Astrocytoma1
Cholangiocarcinoma1
Glioblastoma1
Glioma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.